Stacy Scott, managing director of the Cyber Risk Practice of Kroll, Inc., explains where vaccine supply chains are most vulnerable to cyber attack, and what steps must be taken to protect them.
The pandemic has exposed a flaw in the delivery industry that existed long before the hampered vaccine rollout: an inability to scale fleets quickly and affordably during demand surges.
With the coronavirus pandemic and its lingering effects, companies have now experienced how challenging it can be to plan and maneuver their supply chains around uniquely disruptive, once-in-a-lifetime events. But the unfortunate truth is that less severe events overwhelm or undermine supply planning all the time. Legacy tools are no longer up to the task of getting supply where it is needed most.
Johnson & Johnson will ship some COVID-19 vaccines ordered by the European Union to the U.S. for the last stage of production, raising concern among some member states that the bloc’s inoculation program could be hampered by further delays.
Hundreds of thousands of U.S. mid-market companies bore the financial brunt of the coronavirus pandemic, yet received little to no access to supply-chain finance and revenue management programs. It’s time for that to change.
On top of a faltering vaccine program, which is likely to cost thousands of lives and billions in lost output, the European Commission president and her team have done real damage to the EU and its self-image as a champion of open markets.